Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02864290 |
| Title | A Study to Evaluate Escalating Doses of AGS62P1 Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Astellas Pharma Global Development, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site US00006 | Duarte | California | 91010 | United States | Details | |
| Site US00003 | Baltimore | Maryland | 21287 | United States | Details | |
| Site US00007 | Boston | Massachusetts | 02114 | United States | Details | |
| Site US00009 | Boston | Massachusetts | 02114 | United States | Details | |
| Site US00004 | New York | New York | 10016 | United States | Details | |
| Site US00001 | Houston | Texas | 77030 | United States | Details | |
| Site CA00010 | Toronto | Ontario | M5G 2M9 | Canada | Details |